Genmab A/S (GMAB)

Genmab Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	3,720	3,121	2,390	2,088	1,287
Revenue Growth (YoY)	19.19%	30.59%	14.48%	62.20%	-22.45%
Gross Profit	3,720	3,121	2,390	2,088	1,287
Selling, General & Admin	-	-	-	385.16	196.21
Research & Development	1,606	1,414	1,107	800.55	639.39
Other Operating Expenses	185	43	-	-	-
Total Operating Expenses	1,791	1,457	1,107	1,186	835.59
Operating Income	1,065	972	772	902.03	451.59
Interest Income	408	645	299	459	254.93
Interest Expense	-269	-291	-254	-361.41	-107.35
Total Non-Operating Income (Expense)	139	354	45	97.59	147.57
Pretax Income	1,204	1,326	817	999.61	599.17
Provision for Income Taxes	-	-	-	214.89	146.96
Net Income	963	1,133	631	784.72	452.2
Net Income to Common	963	1,133	631	784.72	452.2
Net Income Growth	-15.00%	79.56%	-19.59%	73.53%	-42.10%
Shares Outstanding (Basic)	622	642	653	654	654
Shares Outstanding (Diluted)	627	647	659	660	660
Shares Change (YoY)	-3.04%	-1.88%	-0.17%	-0.06%	0.24%
EPS (Basic)	1.55	1.77	0.97	1.20	0.69
EPS (Diluted)	1.54	1.75	0.96	1.19	0.68
EPS Growth	-12.32%	82.98%	-19.50%	75.00%	-42.86%
Shares Outstanding	642.38	661.87	660.75	659.62	657.19
Free Cash Flow	1,149	1,099	1,018	517.44	302.18
Free Cash Flow Growth	4.55%	7.96%	96.74%	71.23%	-69.95%
Free Cash Flow Per Share	1.83	1.70	1.54	0.78	0.46
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	28.63%	31.14%	32.30%	43.21%	35.08%
Profit Margin	32.37%	42.49%	34.18%	37.59%	35.13%
FCF Margin	30.89%	35.21%	42.59%	24.78%	23.48%
EBITDA	1,136	1,032	815	954.13	489.52
EBITDA Margin	30.54%	33.07%	34.10%	45.70%	38.03%
EBIT	1,065	972	772	902.03	451.59
EBIT Margin	28.63%	31.14%	32.30%	43.21%	35.08%
Effective Tax Rate	0.00%	0.00%	0.00%	21.50%	24.53%

Updated Feb 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q